Life Sciences & Healthcare
Accelerate drug discovery by identifying molecular interaction laws, binding dynamics, and pharmacokinetic equations from experimental assay data.
One of 34 industries across 8 sectors served by ARDA — the research discovery engine.

The Challenge
Pharmaceutical R&D generates enormous volumes of experimental data — binding assays, ADMET profiling, dose-response curves, pharmacokinetic time-series — yet extracting the governing relationships from this data remains a manual, labor-intensive process. Research teams spend months on curve-fitting, statistical analysis, and hypothesis testing to identify how molecular features relate to biological responses. The data exists in abundance, but the scientific insights encoded within it are locked behind fragmented analytical workflows that scale poorly with the throughput of modern high-content screening and combinatorial chemistry platforms.
Traditional approaches to pharmaceutical data analysis rely on pre-specified model families — Michaelis-Menten kinetics, Hill equations, standard compartmental pharmacokinetic models — that constrain discovery to known functional forms. When the true governing dynamics fall outside these template families, researchers either miss the relationship entirely or force-fit an inappropriate model. Confounding variables in assay data further complicate analysis, as conventional statistical methods struggle to separate genuine molecular interactions from experimental artifacts, batch effects, and correlated but non-causal associations in high-throughput screening campaigns.
The ARDA Approach
ARDA ingests raw experimental data from binding assays, pharmacokinetic studies, and ADMET profiling, then automatically profiles data structure and selects the appropriate discovery mode. Rather than requiring researchers to pre-specify model families, ARDA discovers the governing equations of drug behavior directly from experimental observations. This approach surfaces relationships that template models miss — non-standard dose-response dynamics, unexpected binding cooperativity, multi-compartment pharmacokinetics with non-linear clearance — producing typed scientific claims that capture the actual complexity of molecular interactions.
ARDA's Symbolic mode finds closed-form pharmacokinetic equations governing absorption, distribution, metabolism, and excretion dynamics. The Causal mode (powered by CDE) identifies true causal relationships between molecular features and biological response, separating genuine interactions from confounded associations. Every claim passes through the governance stack: the Truth Dial sets confidence thresholds appropriate for drug development, the Evidence Ledger provides deterministic replay and full provenance, and Negative Controls — bootstrap stability, out-of-distribution testing, feature shuffle — validate that discovered relationships are robust rather than artifacts of experimental noise or data structure.

Discovery Engine
Symbolic and Neuro-Symbolic modes are most critical for pharmaceutical R&D. Symbolic discovery produces the closed-form rate laws and binding equations that pharmacologists require for mechanistic understanding and regulatory submission. Neuro-Symbolic mode handles the high-dimensional assay data common in modern drug discovery — encoding complex molecular features through neural architectures, then distilling interpretable governing equations through symbolic extraction. The Causal mode adds causal graphs mapping how molecular modifications propagate through biological pathways, enabling principled lead optimization grounded in causal evidence rather than empirical correlation alone.

Discovers closed-form governing equations — the explicit mathematical laws that describe how systems behave. Produces human-readable, interpretable formulas.

Deploys physics-informed architectures for high-dimensional, symmetry-rich data where closed-form solutions may not exist.

Combines neural encoding with symbolic distillation — learns complex representations first, then extracts interpretable governing laws from those representations.

The Causal mode, powered by ARDA's Causal Dynamics Engine (CDE), discovers true cause-and-effect relationships from observational data — identifiable causal graphs, regime classifications, and intervention predictions.
Typed Scientific Claims
Every discovery ARDA produces is a typed scientific claim — not a black-box prediction, but a governed, reproducible, auditable piece of scientific knowledge with full provenance.



Governed Discovery
Every discovery ARDA produces carries governance metadata: a truth dial setting that controls the confidence threshold, an evidence ledger entry with deterministic replay recipe, and negative control results including bootstrap stability, out-of-distribution testing, and feature shuffle validation.
For pharmaceutical r&d, this means every scientific claim is auditable, reproducible, and suitable for regulatory submission, peer review, or board-level decision-making. The governance stack is not optional — it is embedded in every discovery run.
Same sector
Discover the causal structures governing biological systems — from CRISPR outcomes to protein folding dynamics — directly from experimental time-series.
ViewIdentify causal treatment effects and patient response dynamics from clinical trial data with ARDA's causal dynamics capability.
ViewDiscover gene regulatory networks and protein interaction dynamics from high-throughput sequencing and mass spectrometry data.
ViewUncover dynamical laws governing neural activity from EEG, fMRI, and electrophysiology recordings.
ViewModel disease transmission dynamics, identify causal risk factors, and discover the governing equations of epidemic spread.
ViewGet started
Whether you are exploring pharmaceutical r&d data for the first time or scaling an existing research programme, ARDA adapts to your workflow. Create an account, connect your data, and let the engine surface the governing laws hidden in your experiments.